Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) announced that researchers are scheduled to present data relating to Soliris® (eculizumab) as a treatment for patients with paroxysmal nocturnal hemoglobinuria (PNH) during the 51st Annual Meeting of the American Society of Hematology (ASH), to be held December 5 – 8, 2009 at the Ernst N. Morial Convention Center in New Orleans.




Researchers To Present Additional Data On Soliris(R) (eculizumab) For The Treatment Of Patients With PNH At The ASH Annual Meeting



Sponsored by Internet Pharmacy - Indian Pharmacy, an online pharmacy supplies more than 600 quality generic medications, free prescription, worldwide shipping.
xanax

Canadian Pharmacy canada pharmacy

Related posts:

  1. Study Details Quality Of Life For Prostate Cancer Patients Four Years Out From Treatment
  2. Data Transfer Solutions Executive a Speaker at Annual Conference of GIS Industry Professionals, N.H.
  3. PPD Dermatology To Present At Second Annual Boston Biotech R&D Conference


canadian pharmacy